De novo design of potent CRISPR-Cas13 inhibitors
Cyntia Taveneau, Her Xiang Chai, Jovita D’Silva, Rebecca S. Bamert, Honglin Chen, Brooke K. Hayes, Roland W. Calvert, Jacob Purcell, Daniel J. Curwen, Fabian Munder, Lisandra L. Martin, Jeremy J. Barr, Joseph Rosenbluh, Mohamed Fareh, Rhys Grinter, Gavin J. Knott
This study designs AI-generated anti-CRISPR proteins that inhibit CRISPR-Cas13 with high potency and specificity.
Nature Chemical Biology · Jan 26, 2026Peer-reviewedBiochemistry